The role of complex genomic alterations in neuroblastoma risk estimation

Por Fischer, Matthias, Berthold, Frank
Publicado em 2010

Reliable Transcript Quantification by Real-Time Reverse Transcriptase-Polymerase Chain Reaction in Primary Neuroblastoma Using Normalization to Averaged Expression Levels of the Co...

Por Fischer, Matthias, Skowron, Matthias, Berthold, Frank
Publicado em 2005

Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015

Por Berthold, Frank, Spix, Claudia, Kaatsch, Peter, Lampert, Fritz
Publicado no Paediatr Drugs (2017)

Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma

Por Krams, Matthias, Hero, Barbara, Berthold, Frank, Parwaresch, Reza, Harms, Dieter, Rudolph, Pierre
Publicado em 2003

Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma

Por Voth, Harald, Oberthuer, André, Simon, Thorsten, Kahlert, Yvonne, Berthold, Frank, Fischer, Matthias
Publicado em 2009

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy

Por Simon, Thorsten, Hero, Barbara, Faldum, Andreas, Handgretinger, Rupert, Schrappe, Martin, Klingebiel, Thomas, Berthold, Frank
Publicado em 2011

Sensitive Detection of Viral Transcripts in Human Tumor Transcriptomes

Por Schelhorn, Sven-Eric, Fischer, Matthias, Tolosi, Laura, Altmüller, Janine, Nürnberg, Peter, Pfister, Herbert, Lengauer, Thomas, Berthold, Frank
Publicado em 2013

Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months

Por Fischer, Janina, Pohl, Alexandra, Volland, Ruth, Hero, Barbara, Dübbers, Martin, Cernaianu, Grigore, Berthold, Frank, von Schweinitz, Dietrich, Simon, Thorsten
Publicado no BMC Cancer (2017)

[(11)C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors

Por Galldiks, Norbert, Kracht, Lutz W., Berthold, Frank, Miletic, Hrvoje, Klein, Johannes C., Herholz, Karl, Jacobs, Andreas H., Heiss, Wolf-Dieter
Publicado em 2009

FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma

Por Ackermann, Sandra, Kocak, Hayriye, Hero, Barbara, Ehemann, Volker, Kahlert, Yvonne, Oberthuer, André, Roels, Frederik, Theißen, Jessica, Odenthal, Margarete, Berthold, Frank, Fischer, Matthias
Publicado no BMC Cancer (2014)

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

Por Khan, Javed, Wei, Jun S., Ringnér, Markus, Saal, Lao H., Ladanyi, Marc, Westermann, Frank, Berthold, Frank, Schwab, Manfred, Antonescu, Cristina R., Peterson, Carsten, Meltzer, Paul S.
Publicado em 2001

High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma

Por Stigliani, Sara, Coco, Simona, Moretti, Stefano, Oberthuer, Andrè, Fischer, Mattias, Theissen, Jessica, Gallo, Fabio, Garavent, Alberto, Berthold, Frank, Bonassi, Stefano, Tonini, Gian Paolo, Scaruffi, Paola
Publicado em 2012

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed

Por Decarolis, Boris, Simon, Thorsten, Krug, Barbara, Leuschner, Ivo, Vokuhl, Christian, Kaatsch, Peter, von Schweinitz, Dietrich, Klingebiel, Thomas, Mueller, Ingo, Schweigerer, Lothar, Berthold, Frank, Hero, Barbara
Publicado no BMC Cancer (2016)

Thalamic high-grade gliomas in children: a distinct clinical subset?

Por Kramm, Christof M., Butenhoff, Sandra, Rausche, Ulrike, Warmuth-Metz, Monika, Kortmann, Rolf-Dieter, Pietsch, Torsten, Gnekow, Astrid, Jorch, Norbert, Janssen, Gisela, Berthold, Frank, Wolff, Johannes E.
Publicado em 2011

Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients

Por Schmitt, Jana, Keller, Andreas, Nourkami-Tutdibi, Nasenien, Heisel, Sabrina, Habel, Nunja, Leidinger, Petra, Ludwig, Nicole, Gessler, Manfred, Graf, Norbert, Berthold, Frank, Lenhof, Hans-Peter, Meese, Eckart
Publicado em 2011

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

Por Rosswog, Carolina, Schmidt, Rene, Oberthuer, André, Juraeva, Dilafruz, Brors, Benedikt, Engesser, Anne, Kahlert, Yvonne, Volland, Ruth, Bartenhagen, Christoph, Simon, Thorsten, Berthold, Frank, Hero, Barbara, Faldum, Andreas, Fischer, Matthias
Publicado no Neoplasia (2017)

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

Por London, Wendy B., Castel, Victoria, Monclair, Tom, Ambros, Peter F., Pearson, Andrew D.J., Cohn, Susan L., Berthold, Frank, Nakagawara, Akira, Ladenstein, Ruth L., Iehara, Tomoko, Matthay, Katherine K.
Publicado em 2011

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets

Por Dorneburg, Carmen, Goß, Annika V., Fischer, Matthias, Roels, Frederik, Barth, Thomas F.E., Berthold, Frank, Kappler, Roland, Oswald, Franz, Siveke, Jens T., Molenaar, Jan J., Debatin, Klaus-Michael, Beltinger, Christian
Publicado no Oncotarget (2016)

cDNA array-CGH profiling identifies genomic alterations specific to stage and <it>MYCN</it>-amplification in neuroblastoma

Por Berthold Frank, Westermann Frank, Son Chang-Gue, Greer Braden T, Krasnoselsky Alexei L, Cenacchi Nicola, Whiteford Craig C, Wei Jun S, Bilke Sven, Chen Qing-Rong, Schwab Manfred, Catchpoole Daniel, Khan Javed
Publicado em 2004-09-01

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

Por Chen, Qing-Rong, Bilke, Sven, Wei, Jun S, Whiteford, Craig C, Cenacchi, Nicola, Krasnoselsky, Alexei L, Greer, Braden T, Son, Chang-Gue, Westermann, Frank, Berthold, Frank, Schwab, Manfred, Catchpoole, Daniel, Khan, Javed
Publicado em 2004